ArticleJournal for immunotherapy of cancer2026

Frontline immunotherapy with response-guided subsequent treatment (FIRST) in cutaneous squamous cell carcinoma: a Bayesian causal analysis of dose intensity, early benefit, and treatment de-escalation.

David M Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.